Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Status:
RECRUITING
Trial end date:
2030-06-30
Target enrollment:
Participant gender:
Summary
This study is being done to answer the following questions: Is the chance of rectal cancer responding the same if chemotherapy alone is given before limited surgery compared to chemotherapy and radiation therapy given together before limited surgery? If radiation therapy is not given, is quality of life better?
Phase:
PHASE3
Details
Lead Sponsor:
Canadian Cancer Trials Group
Collaborators:
Alliance for Clinical Trials in Oncology ECOG-ACRIN Cancer Research Group NRG Oncology SWOG Cancer Research Network